CD4 and COVID-19: In the first wave, moderate and severe COVID-19 patients showed significantly higher levels of granzyme B (GZMB) and expression of CD107a in CD8 cells and CD39 and PD-1 in conventional CD4+ T cells compared to healthy individuals [119].